Table 1.
Baseline Characteristics of Patients with Gout Enrolled in E-visits and Historical Controls
| E-visit Program (n=62) | Controls (n=62) | |
|---|---|---|
| Age, years (mean, SD)1 | 58.0 (12.6) | 58.6 (11.3) |
| Male sex (n, %) | 52 (83.9%) | 49 (79.0%) |
| White (n, %) | 57 (91.9%) | 52 (83.9%) |
| Black (n, %) | 0 | 2 (3.2%) |
| Asian (n, %) | 3 (4.8%) | 4 (6.4%) |
| Other (n, %) | 2 (3.2%) | 4 (6.4%) |
| Hispanic (n, %) | 3 (4.8%) | 1 (1%) |
| Weight, kg (mean, SD)1 | 95.6 (18.9) | 98.7 (20.7) |
| Height, cm (mean, SD)1 | 172.5 (10.8) | 174.3 (10.6) |
| Body mass index, kg/m2 (mean, SD)1 | 32.3 (6.7) | 32.4 (6.3) |
| Creatinine, mg/dL (mean, SD)1 | 1.1 (0.3) | 1.2 (0.4) |
| Mean glomerular filtration rate (mL/min/1.73m2)1-2 |
103.4 (38.5) | 99.0 (36.5) |
| Stage 3, 4, or 5 chronic kidney disease (n, %)3 |
11 (17.7) | 10 (16.1) |
| New start of urate lowering therapy (n, %) |
37 (59.7) | 37 (59.7) |
| New to rheumatology practice (n, %) | 21 (33.9) | 28 (45.2) |
1
Mean values are reported with standard deviation in parentheses
2
Calculated by Cockroft-Gault Equation
3
Stage 3 or worse chronic kidney disease defined as estimated glomerular filtration rate <60 mL/min/1.73m2